Lucila Garcia-Contreras

5PUBLICATIONS
4CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 23, 2023
The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs.

Lucila Garcia-Contreras, Shumaila Nida Muhammad Hanif, Mariam Ibrahim

|Jun 28, 2023
Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data.

Margaret Bourlon, Yu Feng, Lucila Garcia-Contreras

|May 13, 2023
Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications.

Xiaoyu Ren, Changsun Kang, Lucila Garcia-Contreras

|Aug 28, 2021
Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model.

Lucila Garcia-Contreras, Vasu Sethuraman, Masha Kazantseva

|Dec 09, 2017
SHetA2 Dry Powder Aerosols for Tuberculosis: Formulation, Design, and Optimization Using Quality by Design.

Mariam Ibrahim, Manolya Kukut Hatipoglu, Lucila Garcia-Contreras

Pageof 1